Design and characterisation of a minibeam collimator utilising Monte Carlo simulation and a clinical linear accelerator.
Saved in:
| Title: | Design and characterisation of a minibeam collimator utilising Monte Carlo simulation and a clinical linear accelerator. |
|---|---|
| Authors: | Carver, Antony1 (AUTHOR), Baker, Sam2 (AUTHOR) samibaker1997@googlemail.com, Dumbill, Andrew1 (AUTHOR), Horton, Steven1 (AUTHOR), Green, Stuart1 (AUTHOR) |
| Source: | Physics in Medicine & Biology. 7/7/2024, Vol. 69 Issue 13, p1-13. 13p. |
| Subjects: | Linear accelerators, Monte Carlo method, Collimators, Photon beams, Proton therapy |
| Abstract: | Objective. Spatially fractionated radiotherapy is showing promise as a treatment modality. Initial focus was on beams of photons at low energy produced from a synchrotron but more recently research has expanded to include applications in proton therapy. Interest in photon beams remains and this is the focus of this paper Approach. This study presents a 3D printed tungsten minibeam collimator intended to produce peak-to-valley dose ratios (PVDR) of between seven and ten with a 1 MV, bremsstrahlung generated, photon beam. The design of the collimator is motivated by a Monte Carlo study estimating the PVDR for different collimator designs at different energies. This collimator was characterised on a clinical linear accelerator (Elekta VersaHD) as well as an orthovoltage unit. Main results. The performance of the fabricated collimator was measured on Elekta VersaHD running in unflattened mode with a 6 MV beam. On the Elekta VersaHD units the PVDR was measured to be between approximately 1.5 and 2.0 at 3 cm deep. For measurements with the orthovoltage unit PVDRs of greater than 10 were observed at a depth of 4 cm. Significance. The results confirmed that the predictions from simulation could be reproduced on linear accelerators currently in clinical usage, producing PVDRs between 2–2.5. Using the model to predict PVDRs using 1 MV photon beams, the threshold considered to produce enhanced normal tissue dose tolerance ( > 7) was surpassed. This suggests the possibility of using such techniques with versions of existing Linac technology which have been modified to operate at low energy and high beam currents. [ABSTRACT FROM AUTHOR] |
| © 2025 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
Be the first to leave a comment!
